Erica L. Monaco - 01 Jul 2022 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role: Chief Executive Officer
Signature: /s/ Daniel Hakansson, Attorney-in-fact for Erica L. Monaco
Issuer symbol: BFRI
Transactions as of: 01 Jul 2022
Net transactions value: $0
Form type: 4
Filing time: 19 Sep 2022, 08:11:00 UTC
Previous filing: 26 May 2022
Next filing: 22 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BFRI	Common Stock	Options Exercise		+56,689			56,689	01 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BFRI	Restricted Stock Units	Options Exercise	$0	-56,689	-27%	$0.000000	152,672	01 Jul 2022	Common Stock	56,689		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units covert into common stock on a one-for-one basis.
F2	On December 9, 2021, the reporting person was granted 56,689 restricted stock units, vesting on the six-month anniversary of the grant date.